Researchers
Our research is structured into research themes, programs of work and teams. We are committed to collaboration and to work together.

Research theme leaders

BA (Education) PhD Candidate
Director of First Nations Strategy and Leadership; Head, First Nations Health and Equity Research

BSc PhD
Head, Chronic Diseases Research

OAM BSc (Hons) GradDipClinEpi PhD

BSc (Hons) PhD
Head, Brain and Behaviour Research

BSc (Hons) MSc PhD
Feilman Fellow; Head, Precision Health Research and Head, Computational Biology

BMedSci (hons), PhD
Shaping excellence
Rewarding excellence
Learn more about how The Kids rewards research excellence
Learn more about how The Kids rewards research excellenceResearch governance
We pride ourselves on conducting research to the highest standards possible
Find out more about research governanceCurrent career opportunities
Want to join our team and help make a difference to child health?
Learn more about Current career opportunitiesHelp shape our research
Find out how you can involve consumers and the community in your research
Help shape our researchReports & findings
Genome-wide association meta-analysis of childhood ADHD symptoms and diagnosis identifies new loci and potential effector genes
We performed a genome-wide association meta-analysis of 290,134 attention-deficit/hyperactivity disorder symptom measures of 70,953 unique individuals from multiple raters, ages and instruments.
The Koolungar (Children) Moorditj (Strong) Healthy Skin Project Part I: Conducting First Nations Research in Pediatric Dermatology
Integrating First Nations knowledge systems and Western research methodologies recognizes the strength, experience, and insight of First Nations peoples in addressing health issues in their communities. In research, this includes projects being led by First Nations Elders and peoples, including First Nations researchers in the team, and collecting data in ways that reflect First Nations ways of knowing, being, and doing.
Perspectives on the origin and therapeutic opportunities in Down syndrome-associated leukemia
It is now well accepted that germline or de novo genetic alterations predispose to cancer development, especially during childhood. Among them, constitutive trisomy 21, also known as Down syndrome (DS), has been shown to predispose to acute leukemia affecting both the myeloid (ML-DS) and lymphoid (DS-ALL) lineages. ML-DS is associated with a good prognosis compared to children without DS, due in part to a higher sensitivity to conventional chemotherapy.
Transparent reporting of adaptive clinical trials using concurrently randomised cohorts
Adaptive clinical trials have designs that evolve over time because of changes to treatments or changes to the chance that participants will receive these treatments. These changes might introduce confounding that biases crude comparisons of the treatment arms and makes the results from standard reporting methods difficult to interpret for adaptive trials. To deal with this shortcoming, a reporting framework for adaptive trials was developed based on concurrently randomised cohort reporting.